Agfa-gevaert Nv · EURONEXT:AGFB

Agfa-gevaert Nv — Q2 2017 Earnings Presentation

20 slides from Agfa-gevaert Nv's earnings presentation, Aug 23, 2017

  1. Slide 1: Q2 2017 Results

    Q2 2017 Results 23 August 2017

  2. Slide 2: Profit & Loss: Key Figures (in million Euro)

    Profit & Loss: Key Figures (in million Euro) Q2'16 Q2'17 ∆% H1'16 H1'17 ∆% (excl. X-rate) (excl. X-rate) Sales 645 622 -3.6%(-4.6%) 1,248 1,210 -3.0%(-4.3%) Gross Profit* 230 212 -7.8% 425 405 -4.7% as a % of sales 35.7% 34.1% 34.1% 33.5% SG&A* -129 -129 0.0% -256 -258 0.8% as % of sales 20.0% 20.7%

  3. Slide 3: Profit & Loss: Key Figures (in million Euro)

    Profit & Loss: Key Figures (in million Euro) Q2 '16 Q2 '17 ∆% H1 '16 H1 '17 ∆% Recurring EBIT* 64 47 -26.6% 98 73 -25.5% Restructuring and non-recurring 10 -2 6 -5 Operating result 74 45 -39.2% 104 68 -34.6% Non-operating result -21 -8 -29 -20 Profit before taxes 53 37 75 48 Taxes -13 -10 -25 -13 Ne

  4. Slide 4: Net Financial Debt (in million Euro)

    Net Financial Debt (in million Euro) 191 176 175 126 94 102 83 58 52 40 31 Q4’16 Q1’17 27 -18 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'16 Q2'16 Q3'16 Q4'16 Q1'17 -37 Q2'17 4

  5. Slide 5: Working Capital: Key Figures (in million Euro/days)

    Working Capital: Key Figures (in million Euro/days) 800 Inventories 800 Trade Receivables* 800 Trade Payables 700 700 700 600 600 600 580 577 575 561 563 544 542 537 531 534 500 512 512 528 500 500 483 400 400 421 400 413 399 388 384 371 363 374 364 300 349 351 337 300 300 324 330 112 114 115114111

  6. Slide 6: Main Group Drivers behind Key Figures

    Main Group Drivers behind Key Figures Q2 2017 • Good performance of most of the growth engines • Top line impacted by the reorganization of the hardcopy distribution channels in China • Net profit of 27 million Euro • Net financial debt of 27 million Euro 6

  7. Slide 7: Graphics

    Graphics AGFA

  8. Slide 8: Graphics: YTD Sales per Business Segment

    Graphics: YTD Sales per Business Segment 1H 2017 100% = 609 million Euro Inkjet, Software, Service 24% Analog Prepress Digital 10% Prepress 66% 8

  9. Slide 9: Graphics: Key Figures (in million Euro)

    Graphics: Key Figures (in million Euro) Q2'16 Q2'17 ∆% H1'16 H1'17 ∆% (excl. curr.) (excl. curr. ) Sales 321 309 -3.7%(-4.4%) 628 609 -3.0%(-4.3%) Gross Profit* 100 93 -7.0% 189 183 -3.2% as a % of sales 31.2% 30.1% 30.1% 30.0% SG&A* -67 -65 -3.0% -132 -131 -0.8% as % of sales 20.9% 21.0% 21.0% 21.5

  10. Slide 10: Graphics: Main Drivers behind Key Figures

    Graphics: Main Drivers behind Key Figures Q2 2017 • Based on the strong performance of the Anapurna wide-format equipment product range and the substantial increase in ink volumes for both wide-format and industrial applications, the Inkjet segment posted double-digit top line growth. In the prepres

  11. Slide 11: HealthCare

    HealthCare AGFA

  12. Slide 12: HealthCare: YTD Sales per Business Segment

    HealthCare: YTD Sales per Business Segment 1H 2017 100% = 503 million Euro Hardcopy 25% Classic Radiology 5% CR/Modalities 21% Imaging IT Solutions* HCIS 31% 18% HealthCare IT = 49% * Includes Radiology and Cardiology IT 12

  13. Slide 13: HealthCare: Key Figures (in million Euro)

    HealthCare: Key Figures (in million Euro) Q2'16 Q2'17 ∆% H1'16 H1'17 ∆% (excl. curr.) (excl. curr. ) Sales 277 264 -4.7%(-6.2%) 531 503 -5.3%(-6.9%) Gross Profit* 116 105 -9.5% 213 196 -8.0% as a % of sales 41.9% 39.8% 40.1% 39.0% SG&A* -56 -58 3.6% -111 -115 3.6% as % of sales 20.2% 22.0% 20.9% 22.

  14. Slide 14: HealthCare: Main Drivers behind Key Figures

    HealthCare: Main Drivers behind Key Figures Q2 2017 • The DR growth engine performed well, while the HealthCare Information Solutions range posted continuous top line and order book growth. The Imaging IT Solutions range saw a temporary slowdown, but the continuously strong order book for the Enterp

  15. Slide 15: Specialty Products

    Specialty Products AGFA

  16. Slide 16: Specialty Products: Key Figures (in million Euro)

    Specialty Products: Key Figures (in million Euro) ∆% ∆% Q2 '16 Q2 '17 (excl. curr.) H1'16 H1'17 (excl. curr.) Sales 47 49 4.3%(4.1%) 89 98 10.1%(9.7%) Gross profit* 13 14 7.7% 23 26 13.0% as a % of sales 27.7% 28.6% 25.8% 26.5% SG&A* -7 -7 0.0% -13 -13 0.0% as a % of sales 14.9% 14.3% 14.6% 13.3% R&

  17. Slide 17: Specialty Products: Main Drivers behind Key Figures

    Specialty Products: Main Drivers behind Key Figures Q2 2017 • Agfa Specialty Products’ revenue increased to 49 million Euro. The future-oriented businesses (mainly Synaps Synthetic Paper and Orgacon Electronic Materials), the Printed Circuit Board business, as well as a number of classic film produc

  18. Slide 18: Study aiming at focused growth

    Study aiming at focused growth

  19. Slide 19: Agfa announces study aiming at focused growth

    Agfa announces study aiming at focused growth • Agfa-Gevaert NV (Agfa) today announced that the Board of Directors has asked the Management to study how to organise the HealthCare IT activities into a stand-alone legal entity structure and organisation within the Agfa- Gevaert Group. • Increasing th

  20. Slide 20: Questions & Answers

    Questions & Answers AGFA

Agfa-Gevaert — Q2 2017 Earnings Presentation on 6ix